Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
Pediatric Studies Characteristics - Detail
FDA Home
Pediatrics
Pediatric Studies Characteristics
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Approval Date:
03/26/2012
Trade Name:
Intelence
Generic or Proper Name (*):
etravirine
Indications Studied:
Treatment of HIV-1 infection in combination with other antiretroviral agents
Therapeutic Category:
Antiviral
Ages Studied:
6 - < 18 years
Study #:
2
Study Type:
Efficacy/Safety/Tolerability
Study Design:
Open Label
No Patients:
101
No Centers:
42
No Countries:
13
BPCA(B), PREA(P):
B,P
White:
49
Countries:
Argentina, Brazil, Canada, France, Italy, Portugal, Puerto Rico, Romania, South Africa, Spain, Thailand, United Kingdom, United States
-
-